CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Common Stock	Additional Paid-in Capital Adjustment	Additional Paid-in Capital	Accumulated Deficit Adjustment	Accumulated Deficit	Adjustment	Total
Beginning balance (ASU 2020-06) at Dec. 31, 2023			$ (393)		$ 224		$ (169)
Beginning balance at Dec. 31, 2023		$ 73		$ 415,045		$ (381,549)		$ 33,569
Beginning balance (in shares) at Dec. 31, 2023	[1]	72,952,124
Share-based compensation related to stock options				1,191				1,191
Share-based compensation related to restricted stock awards		$ 1		1,407				1,408
Share-based compensation related to restricted stock awards (in shares)	[1]	681,459
Net Income (Loss)						(3,562)		(3,562)
Ending balance at Sep. 30, 2024		$ 74		417,250		(384,887)		32,437
Ending balance (in shares) at Sep. 30, 2024	[1]	73,633,583
Beginning balance at Jun. 30, 2024		$ 73		416,631		(388,123)		28,581
Beginning balance (in shares) at Jun. 30, 2024	[1]	73,292,674
Share-based compensation related to stock options				358				358
Share-based compensation related to restricted stock awards		$ 1		261				262
Share-based compensation related to restricted stock awards (in shares)	[1]	340,909
Net Income (Loss)						3,236		3,236
Ending balance at Sep. 30, 2024		$ 74		417,250		(384,887)		32,437
Ending balance (in shares) at Sep. 30, 2024	[1]	73,633,583
Beginning balance at Dec. 31, 2024		$ 76		421,528		(378,393)		43,211
Beginning balance (in shares) at Dec. 31, 2024	[1]	75,850,275
Issuance of common stock under the Sales Agreement, net		$ 3		6,809				6,812
Issuance of common stock under the Sales Agreement, net (in shares)	[1]	2,775,215
Share-based compensation related to stock options				1,004				1,004
Share-based compensation related to restricted stock awards				561				561
Share-based compensation related to restricted stock awards (in shares)	[1]	559,210
Exercise of warrants and options		$ 1		2,419				2,420
Exercise of warrants and options (in shares)	[1]	1,156,625
Net Income (Loss)						(1,100)		(1,100)
Ending balance at Sep. 30, 2025		$ 80		432,321		(379,493)		52,908
Ending balance (in shares) at Sep. 30, 2025	[1]	80,341,325
Beginning balance at Jun. 30, 2025		$ 80		431,671		(381,848)		49,903
Beginning balance (in shares) at Jun. 30, 2025	[1]	79,732,115
Share-based compensation related to stock options				405				405
Share-based compensation related to restricted stock awards				193				193
Share-based compensation related to restricted stock awards (in shares)	[1]	559,210
Exercise of warrants and options				52				52
Exercise of warrants and options (in shares)	[1]	50,000
Net Income (Loss)						2,355		2,355
Ending balance at Sep. 30, 2025		$ 80		$ 432,321		$ (379,493)		$ 52,908
Ending balance (in shares) at Sep. 30, 2025	[1]	80,341,325

[1] Common stock, $0.001 par value; Authorized – as of September 30, 2025 and December 31, 2024 – 185,000,000 shares.